Patent ID: 8158362

Claim:
A method of detecting an LTA 4 H haplotype associated with myocardial infarction (MI) risk in a human individual and assessing susceptibility to MI in said human individual, comprising assaying a nucleic acid-containing sample obtained from the human individual to detect therein the presence of an LTA 4 H haplotype associated with MI risk, wherein the LTA 4 H haplotype comprises polymorphisms SG12S16 having allele C, SG12S21 having allele G, SG12S23 having allele T, SG12S25 having allele A, SG12S26 having allele T, SG12S100 having allele T, SG12S28 having allele T, SG12S143 having allele C, SG12S144 having allele G, and SG12S221 having allele G, wherein the presence of the LTA 4 H haplotype in the nucleic acid-containing sample identifies the individual as having elevated susceptibility to MI.